Hematopoiesis News Volume 14.13 | Apr 04 2023

    0
    23







    2023-04-04 | HN 14.13


    Hematopoiesis News by STEMCELL Technologies
    Vol. 14.13 – 4 April, 2023
    TOP STORY

    Activation of Lineage Competence in Hemogenic Endothelium Precedes the Formation of Hematopoietic Stem Cell Heterogeneity

    Using a combination of single-cell multi-omics, lineage tracing, and functional assays, investigators showed that embryonic hematopoietic stem and progenitor cells originate from heterogeneous hemogenic endothelial cells during zebrafish embryogenesis.
    [Cell Research]

    Abstract
    Find out the estimated cell frequencies and percentages of more than 35 cell types in normal human blood-related sources.
    PUBLICATIONSRanked by the impact factor of the journal

    Exposure of Newborns to Atmospherically Relevant Artificial Particulate Matter Induces Hematopoietic Stem Cell Senescence

    Scientists investigated how exposure to atmospherically relevant artificial particulate matter of diameter less than 2.5 µm affected hematopoietic stem and progenitor cells in newborns. [Journal Of Hazardous Materials]

    Full ArticleGraphical Abstract

    Tespa1 Facilitates Hematopoietic and Leukemic Stem Cell Maintenance by Restricting C-myc Degradation

    Investigators observed that the expression of thymocyte-expressed, positive selection-associated 1 (Tespa1) was markedly increased in HSCs after stress exposure.
    [Leukemia]

    Full Article

    In Vivo RNA Delivery to Hematopoietic Stem and Progenitor Cells via Targeted Lipid Nanoparticles

    Researchers developed a c-kit antibody-targeted lipid nanoparticle that, following a single intravenous injection, can deliver RNA to HSCs in vivo in rodents.
    [Nano Letters]

    AbstractGraphical Abstract

    Loss of Dnmt3a Impairs Hematopoietic Homeostasis and Myeloid Cell Skewing via the PI3Kinase Pathway

    Scientists showed that loss of Dnmt3a in hematopoietic stem cells and progenitors resulted in myeloproliferation, which was associated with hyperactivation of the PI3Kinase pathway.
    [JCI Insight]

    AbstractGraphical Abstract

    Erythroferrone Exacerbates Iron Overload and Ineffective Extramedullary Erythropoiesis in a Mouse Model of β-Thalassemia

    To analyze the effect of high erythroferron (ERFE) concentrations on hepcidin and iron overload in non-transfusion-dependent β-thalassemia, investigators crossed Th3/+ mice with erythroid ERFE-overexpressing transgenic mice.
    [Blood Advances]

    Abstract

    Congenic Hematopoietic Stem Cell Transplantation Promotes Survival of Heart Allografts in Murine Models of Acute and Chronic Rejection

    Researchers investigated whether autologous HSC transplantation could promote tolerance to heart allografts in mice.
    [Clinical & Translational Immunology]

    Abstract
    Graphical Abstract

    Glucose Induced-AKT/mTOR Activation Accelerates Glycolysis and Promotes Cell Survival in Acute Myeloid Leukemia

    Glucose and 2-deoxy-D-glucose treatment were applied to analyze the relationship between glucose metabolism and cell survival.
    [Leukemia Research]

    AbstractGraphical Abstract

    Clonal Hematopoiesis Detection in Patients with Cancer Using Cell-Free DNA Sequencing

    Scientists presented an accurate classification approach to determine the clonal hematopoiesis status from cell-free DNA (cfDNA) sequencing alone, applying their model to 4324 oncology clinical cfDNA samples.
    [Science Translational Medicine]

    Full Article

    Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors

    For children undergoing autologous hematopoietic stem cell transplantation for central nervous system tumors, increasing CD34+ cell dose was associated with significantly improved overall survival and progression-free survival without increased non-relapse mortality or endothelial-injury complications.
    [Transplantation And Cellular Therapy]

    Abstract
    Webinar: Bone Marrow Skeletal Progenitors and Bone Diseases
    REVIEWS

    Pre-Emptive and Prophylactic Donor Lymphocyte Infusion Following Allogeneic Stem Cell Transplantation

    The authors discuss the efficacy and risks of donor lymphocyte infusion, with a focus on pre-emptive and prophylactic use.
    [International Journal Of Hematology]

    Abstract

    Regulation of Hematopoiesis by Hedgehog Signaling

    Investigators highlight recent findings focused on Hedgehog signaling in the regulation of hematopoietic development during the early embryonic stage, and the proliferation and differentiation of hematopoietic stem and progenitor cells in adults.
    [Molecular Medicine Reports]

    Abstract
    INDUSTRY AND POLICY NEWS

    Disc Medicine Announces Collaboration with National Institutes of Health for Phase II Clinical Study of Bitopertin in Patients with Diamond-Blackfan Anemia (DBA)

    Disc Medicine, Inc. announced a collaboration with the National Heart Lung and Blood Institute of the National Institutes of Health to evaluate bitopertin, a therapeutic candidate designed to modulate heme biosynthesis, in a Phase II clinical study of patients with DBA.
    [Disc Medicine, Inc.]

    Press Release
    FEATURED EVENT

    Frontiers in Immunology

    April 11 – 12, 2023
    New York, New York, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Cancer Metabolism, Epigenetics, Hematopoiesis

    University of Texas Health Science Center – San Antonio, Texas, United States

    PhD Project – Biomimetic ECM Coatings

    University of Birmingham – Birmingham, England, United Kingdom

    Postdoctoral Associate – Cancer Stem Cell Biology

    Baylor College of Medicine – Houston, Texas, United States

    Postdoctoral Associate – Integrated Systems Biology of AML

    University of Florida – Gainesville, Florida, United States

    Research Assistant – Myeloid Blood Cancers

    King’s College London – Strand, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hematopoiesis News Twitter